Language:
Currency:
2 ITEMS - $351.98 Bonus: 3
Your cart

Imodium Imodium 2 mg x 360 pills
$ 134.99 $ 134.99
Augmentin Augmentin 250/125 mg x 120 pills
Update 120 pills to 180 pills and save $ 302.40
$ 216.99 $ 216.99
Shipping method:
Delivery Insurance:
(Free reshipment if delivery fails)
  $ 5.50  
Pay at our secure server: $ 357.48  
Our discount gifts for all reliable consumers:
10% discount for all next orders 10% discount for all next orders
Free standard airmail service for all orders with sum starting at $200 Free standard airmail service for all orders with sum starting at $200
Free trackable courier service for all orders with sum starting at $300 Free trackable courier service for all orders with sum starting at $300


Testimonials
Dave, London, UK
“Hi everybody, I am Dave from UK. Erection has become a problem for me since I put on a lot of weight and fought with obesity for years. I did not want to surrender. I had nothing to lose and ordered Cialis. I take it once in 7 days, this weekend tab, ...
Geoffrey Stidworthy, EAST MELBOURNE, Australia
My apologies. I did not know the items were sent separately. I received the second envelope yesterday. Thank you for your help and support. Have a great day.
Austin, 64, Austria
“Wow, I've never felt like that since I was a youngster! Only being a student I could make love like that and have multiple erections in a short while after taking this magic pill. Viagra is really a deed for the man who was present at 40 classmate reunions ...
Read more...

Shipping Option

Secure Payment Process
News
Cancer pill gave me 'four years of extra time'
More than 1,000 women a year with advanced cancer could benefit from capivasertib which can slow the disease.
Saliva test may turn tide on prostate cancer, claim scientists
Analysing DNA in saliva can identify men at the greatest risk of prostate cancer
What goes on inside toddlers' brains?
A unique study is tracking the development of hundreds of babies whose parents have also been studied since birth.
Infected blood victims losing faith as inquiry hearings restart
Inquiry chair is acting amid grave concerns over payouts to victims after final report was published last year.